Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00370318 | Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines | PHASE3 | COMPLETED | 400 | — | — | Sep 1, 2006 | Apr 1, 2007 | Mar 23, 2017 | 10 | Czechia |
| Name | Type | Description |
|---|---|---|
| 10 valent pneumococcal conjugate vaccine | BIOLOGICAL | - |
| Infanrix Hexa | BIOLOGICAL | - |
| Rotarix | BIOLOGICAL | - |
| Paracetamol | DRUG | - |
Inclusion Criteria: * Healthy children 9-16 weeks old and born after a gestation of at least 36 weeks. Exclusion Criteria: * Body weight \< 4.5 kg * Children having received or planning to receive any investigational or non-registered products, vaccines not foreseen in the protocol, and immune mo...